Search research articles
Contact Us
Filters
Showing results (191-200 of 221) with videos related to
Page
of 23
Sort By:
European Journal of Immunology
|
August 14, 2001
Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection
A M Grabowska, F Lechner, P Klenerman, et al.
International Journal of Cancer
|
March 12, 1992
An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours
L G Durrant, G W Denton, E Jacobs, et al.
Diabetes, Obesity & Metabolism
|
August 14, 2025
Orforglipron, an oral non-peptide glucagon-like peptide-1 receptor agonist, improves markers of β-cell function and insulin sensitivity in type 2 diabetes
Julio Rosenstock, Deborah A Robins, Kevin L Duffin, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 12, 2007
An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb
S J Wigginton, P B Furtado, K L Armour, et al.
British Medical Journal (Clinical Research Ed.)
|
March 23, 1985
Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator
I O Ellis, C P Hinton, J MacNay, et al.
Diabetes, Obesity & Metabolism
|
January 19, 2021
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes
Jonathan M Wilson, Amir Nikooienejad, Deborah A Robins, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1987
Identification of a monoclonal antibody-defined breast carcinoma antigen in body fluids
M R Price, G Crocker, S Edwards, et al.
British Journal of Cancer
|
April 1, 1987
Tumour aneuploidy, prognostic parameters and survival in primary breast cancer
A A Owainati, R A Robins, C Hinton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2006
A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55
Gustav J Ullenhag, Ian Spendlove, Nicholas F S Watson, et al.
Diabetes Care
|
April 16, 2020
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
Mark L Hartman, Arun J Sanyal, Rohit Loomba, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 221) with videos related to
Sort By:
Page
of 23
European Journal of Immunology
|
August 14, 2001
Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection
A M Grabowska, F Lechner, P Klenerman, et al.
International Journal of Cancer
|
March 12, 1992
An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours
L G Durrant, G W Denton, E Jacobs, et al.
Diabetes, Obesity & Metabolism
|
August 14, 2025
Orforglipron, an oral non-peptide glucagon-like peptide-1 receptor agonist, improves markers of β-cell function and insulin sensitivity in type 2 diabetes
Julio Rosenstock, Deborah A Robins, Kevin L Duffin, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 12, 2007
An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb
S J Wigginton, P B Furtado, K L Armour, et al.
British Medical Journal (Clinical Research Ed.)
|
March 23, 1985
Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator
I O Ellis, C P Hinton, J MacNay, et al.
Diabetes, Obesity & Metabolism
|
January 19, 2021
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes
Jonathan M Wilson, Amir Nikooienejad, Deborah A Robins, et al.
European Journal of Cancer & Clinical Oncology
|
August 1, 1987
Identification of a monoclonal antibody-defined breast carcinoma antigen in body fluids
M R Price, G Crocker, S Edwards, et al.
British Journal of Cancer
|
April 1, 1987
Tumour aneuploidy, prognostic parameters and survival in primary breast cancer
A A Owainati, R A Robins, C Hinton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 24, 2006
A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55
Gustav J Ullenhag, Ian Spendlove, Nicholas F S Watson, et al.
Diabetes Care
|
April 16, 2020
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
Mark L Hartman, Arun J Sanyal, Rohit Loomba, et al.
Page
of 23